Top Story

Publication Exclusive: Updates on surgical techniques for pediatric cataract surgery

October 4, 2015

Globally, congenital cataracts account for 5% to 20% of blindness in children, and these numbers differ in various countries. In the U.S., the prevalence of visually significant infantile cataract was estimated to be three or four per 10,000 live births. Congenital cataracts may involve one or both eyes and can span a wide spectrum of lens opacities, from a visually insignificant, small, focal opacity not involving the visual axis to total lens opacification. Hence, treatment strategies will vary depending on the type of lens opacity. The overall focus is to clear the visual axis in a timely fashion to prevent potential lifelong amblyopia.

Extent and location of the congenital cataract, combined with presenting age, are important factors that determine whether or not surgical intervention is indicated. If surgery can safely be delayed until eye growth stabilization has been attained and IOL implantation is appropriate, temporary nonsurgical avenues may be pursued, including pupillary dilation with tropicamide or phenylephrine; also, avoiding amblyogenic atropine may be appropriate. In selected cases, part-time occlusion may be required to prevent amblyopia. When surgical intervention is necessary, the type of procedure would be influenced by presenting age, and the surgeon should be familiar with the various complexities in the overall management of pediatric cataracts. A pediatric ophthalmologist should be an integral part of the overall team approach, along with family support, for an optimal outcome.

VIDEO: Choroidal graft transplantation for patients with AMD Meeting News CoverageVideo

VIDEO: Choroidal graft transplantation for patients with AMD

October 3, 2015
NICE, France — At the Euretina meeting, Grazia Pertile, MD, talks about choroidal graft transplantation, a surgical option for AMD patients who cannot benefit from…
In the Journals

Study: Only half of patients undergo appropriate screening for hydroxychloroquine toxicity

October 2, 2015
Slightly more than half of patients who presented for hydroxychloroquine toxicity screening received appropriate evaluation, according to a study.The American Academy of…
Breaking News

Oraya Therapy maintains vision, reduces injections in wet AMD treatment at 1 year

October 2, 2015
Oraya Therapy maintained vision and reduced the number of anti-VEGF injections in the treatment of wet age-related macular degeneration, according to an Oraya…
Richard L. Lindstrom

Richard L. Lindstrom pays tribute to Jan Worst

October 2, 2015
Jan Worst, MD, was a unique man and ophthalmologist. I have never met anyone quite like him.I met him when I attended the first European Society of Cataract and…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
Vitreomacular Adhesion

Vitreomacular Adhesion: Addressing Patient Selection and Safety Concerns for Optimal Treatment

This activity is supported by an educational grant from ThromboGenics.

Clinicians gained a new option for the management of vitreomacular adhesion in 2012 with the FDA approval of a…
More »
Meeting News Coverage Video
VIDEO: Speaker discusses strategies for treating patients with ocular trauma

VIDEO: Speaker discusses strategies for treating patients with ocular trauma

October 1, 2015
NICE, France — At the Euretina meeting, Sundaram Natarajan, MD, gives highlights from the symposium, Newer…
More »